To investigate the biological functions of CDKN2A in LGG, in which cancer type the CDKN2A could predict the prognosis, we firstly detected the expression of p16 in clinical LGG samples and designed siRNAs to target the CDKN2A expression. The gene discussed is CDKN2A; the disease is cancer.